A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors
Eli Lilly and Company
Eli Lilly and Company
Pfizer
Verastem, Inc.
Pfizer
Eli Lilly and Company
Actuate Therapeutics Inc.
Canadian Cancer Trials Group
Fox Chase Cancer Center
Fox Chase Cancer Center
Celgene
AbbVie